imiquimod has been researched along with 2019 Novel Coronavirus Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 9 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, J; Dellavalle, RP; Maghfour, J; Mamo, A; Olayinka, JT; Runion, TM; Sivesind, TE; Szeto, MD | 1 |
| Cerps, S; Hvidtfeldt, M; Menzel, M; Nieto-Fontarigo, JJ; Porsbjerg, C; Ramu, S; Sander, AF; Sverrild, A; Tillgren, S; Uller, L | 1 |
| Chang, PD; Chang, YT; Chen, PL; Cheng, CM; Cheng, KH; Fu, YC; Ko, WC; Liu, CC; Shen, CF; Shen, TC; Shieh, CC; Yen, CL | 1 |
| Bu, W; Eckenhoff, RG; Koutsogiannaki, S; Maisat, W; Manzor, M; Ohto, U; Yuki, K; Zhang, Z | 1 |
| Dummer, R; Roshardt Prieto, NM; Wyss, M | 1 |
| Farsalinos, K; Poulas, K; Zanidis, C | 1 |
| Alexandris, N; Angelopoulou, A; Farsalinos, K; Konstantinou, E; Mesiakaris, K; Poulas, K; Zanidis, C | 1 |
| Avcilar, H; Eken, A | 1 |
| Banfi, G; Bridgewood, C; Damiani, G; Dunsmuir, R; El-Sherbiny, YM; Khan, A; Loughenbury, P; Malagoli, P; McGonagle, D; Millner, PA; Pigatto, PDM; Rao, A; Rowe, H; Russell, T; Sharif, K; Timothy, J; Vadakekolathu, J; Watad, A; Zhou, Q | 1 |
1 review(s) available for imiquimod and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Interferon and Toll-Like Receptor 7 Response in COVID-19: Implications of Topical Imiquimod for Prophylaxis and Treatment.
Topics: Adjuvants, Immunologic; Administration, Topical; Animals; Antiviral Agents; COVID-19; Humans; Imiquimod; Immunity, Innate; Interferons; SARS-CoV-2; Toll-Like Receptor 7; Up-Regulation | 2021 |
8 other study(ies) available for imiquimod and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.
Topics: Adjuvants, Immunologic; Adult; Aged; Angiotensin-Converting Enzyme 2; Asthma; Bronchi; Cells, Cultured; COVID-19; Female; Humans; Imiquimod; Interferon-beta; Male; Middle Aged; Respiratory Mucosa; SARS-CoV-2 | 2021 |
Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.
Topics: Adult; Aged; Antibodies, Neutralizing; Antibodies, Viral; B-Lymphocytes; ChAdOx1 nCoV-19; COVID-19; Female; Humans; Imiquimod; Immunity, Innate; Immunosenescence; Interferon-gamma; Killer Cells, Natural; Male; Middle Aged; Poly I-C; SARS-CoV-2; Toll-Like Receptors; Vaccination | 2022 |
Propofol directly binds to and inhibits TLR7.
Topics: Animals; COVID-19; Dendritic Cells; Humans; Hypnotics and Sedatives; Imiquimod; Interferon-alpha; Interferon-beta; Mice; Propofol; RNA, Viral; SARS-CoV-2; Toll-Like Receptor 7 | 2022 |
mRNA COVID 19 vaccine-induced recall dermatitis after topical imiquimod.
Topics: Administration, Topical; Aminoquinolines; COVID-19; COVID-19 Vaccines; Dermatitis; Humans; Imiquimod; RNA, Messenger | 2023 |
Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
Topics: Adjuvants, Immunologic; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Imiquimod; Immunity, Innate; Pandemics; Pneumonia, Viral; SARS-CoV-2; Toll-Like Receptor 7 | 2020 |
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.
Topics: Adaptive Immunity; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Humans; Imiquimod; Immunity, Innate; Pandemics; Pneumonia, Viral; SARS-CoV-2; Toll-Like Receptor 7 | 2020 |
Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?
Topics: Adjuvants, Immunologic; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Imiquimod; Immunity, Innate; Models, Immunological; Pandemics; SARS-CoV-2; Skin Cream; Toll-Like Receptor 7 | 2020 |
SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights.
Topics: Adjuvants, Immunologic; Adult; Aged; Arthritis, Psoriatic; Computational Biology; COVID-19; Cyclic Nucleotide Phosphodiesterases, Type 4; Dendritic Cells; Female; Gene Expression Regulation; Humans; Imiquimod; Interferon-alpha; Janus Kinases; Male; Middle Aged; NF-kappa B; Oligonucleotides; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 9; Transcriptome; Tumor Necrosis Factor-alpha | 2021 |